VB Spine to acquire rights to Augmedics’ CT-Fluoro technology

Salong Debbarma

Wed, July 8, 2026 astatine 5:48 AM CDT 1 min read

US-based aesculapian exertion institution VB Spine has signed a definitive statement with Augmedics to get the exclusive rights to the computed tomography-to-fluoroscopy (CT-Fluoro) exertion for spine applications.

The statement follows VB Spine's earlier acquisition of the exclusive rights to the Augmedics xvision Spine System platform.

The CT-Fluoro exertion enables surgeons to registry a patient's preoperative CT scan utilizing modular fluoroscopic imaging.

This process could trim reliance connected intraoperative CT oregon 3D imaging systems during spinal procedures, perchance broadening workflow options and reducing imaging requirements.

VB Spine stated that the exertion is intended to summation accessibility to augmented world navigation for a wider assortment of facilities and surgical settings.

VB Spine co-CEO Marc Viscogliosi said: "At VB Spine, our extremity is to region barriers that forestall surgeons from accessing technologies that amended procedural ratio and diligent care.

"The summation of CT-Fluoro exertion for spine applications volition beryllium an important measurement guardant for the xvision level due to the fact that it provides surgeons with greater flexibility successful however they utilise navigation."

VB Spine noted that pursuing the completion of the transaction, it plans to marque the CT-Fluoro exertion disposable arsenic portion of its portfolio for spine-related procedures.

The statement is taxable to modular closing conditions and regulatory approvals. Specific fiscal details person not been disclosed.

Earlier this year, VB Spine agreed to get the SpineHawk intraoperative spinal visualisation level from Robotron Surgical Technologies.